Kidney transplantation is the treatment of choice for end-stage renal disease, achieving improved outcomes compared to dialysis at a lower cost.1 Moreover, compared to dialysis, transplantation significantly improves a patient’s quality of life (QoL) in terms of physical and psychological function.2 Adequate immunosuppression is mandatory for short- and long-term survival of the kidney transplant, and within the last decade, innovations in immunosuppressive regimens have achieved a significant reduction in acute rejection rates.